Should clinical trials prove positive, Humanigen envisions applying for a BLA, and based on the strength of its data obtaining emergency use authorization (EUA) for lenzilumab, followed by a launch of initial commercial activities as soon as the fourth quarter.
Sygnature Chemical Services will help Heptares Therapeutics progress one of its internal GPCR programs. Sygnature will use its synthetic chemistry expertise to produce a...
Industry experts describe how viral safety testing is evolving to ensure that gene therapies and viral-mediated therapies move more quickly to clinic.
Deal would expand buyer’s oncology pipeline with tucatinib, a breast cancer candidate now under study in a pivotal Phase II trial in patients with HER2+ metastatic breast cancer
Cambrex has agreed to be acquired by an affiliate of the global investment firm Permira for approximately $2.4 billion, in a deal the company said will position it for further growth in the consolidating contract development and manufacturing organization (CDMO) sector.
Firm will take on study start-up and site monitoring.
Partners pledge to support clinical trials, create collaborations between European and African countries.
On the centenary of Rosalind Franklin’s birth, GEN declares that her example tells us that all women scientists deserve recognition. GEN sought to highlight scientists at the forefront of COVID-19 research—some of the most influential research currently being conducted—who are women. These researchers are leading efforts to track SARS-CoV-2 genomes, to uncover host factors influencing COVID-19 progression, to develop saliva-based COVID-19 tests, and more.